Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,719 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emerging Immunotargets in Bladder Cancer.
Massari F, Ciccarese C, Vau N, Santoni M, Montironi R, Cheng L, Marques RC, Scarpelli M, Fonseca J, Matrana MR, Holger M, Cascinu S, Tortora G, Lopez-Beltran A. Massari F, et al. Among authors: fonseca j. Curr Drug Targets. 2016;17(7):757-70. doi: 10.2174/1389450117666160201105537. Curr Drug Targets. 2016. PMID: 26844572
Rare entities in urinary bladder pathology.
Lopez-Beltran A, Marques RC, Montironi R, Reymundo C, Fonseca J, Cheng L. Lopez-Beltran A, et al. Among authors: fonseca j. Anal Quant Cytopathol Histpathol. 2015 Feb;37(1):14-22. Anal Quant Cytopathol Histpathol. 2015. PMID: 26072630 Review.
Dysplasia and carcinoma in situ of the urinary bladder.
Lopez-Beltran A, Marques RC, Montironi R, Reymundo C, Fonseca J, Cheng L. Lopez-Beltran A, et al. Among authors: fonseca j. Anal Quant Cytopathol Histpathol. 2015 Feb;37(1):29-38. Anal Quant Cytopathol Histpathol. 2015. PMID: 26072632 Review.
Tp53 and its potential therapeutic role as a target in bladder cancer.
Ciccarese C, Massari F, Blanca A, Tortora G, Montironi R, Cheng L, Scarpelli M, Raspollini MR, Vau N, Fonseca J, Lopez-Beltran A. Ciccarese C, et al. Among authors: fonseca j. Expert Opin Ther Targets. 2017 Apr;21(4):401-414. doi: 10.1080/14728222.2017.1297798. Epub 2017 Mar 1. Expert Opin Ther Targets. 2017. PMID: 28281901 Review.
Urinary continence recovery after Retzius-sparing robot-assisted radical prostatectomy in relation to surgeon experience.
Fonseca J, Froes G, Moraes-Fontes MF, Rebola J, Lúcio R, Almeida M, Muresan C, Palmas A, Gaivão A, Matos C, Santos T, Dias D, Sousa I, Oliveira F, Ribeiro R, Lopez-Beltran A, Fraga A. Fonseca J, et al. J Robot Surg. 2023 Oct;17(5):2503-2511. doi: 10.1007/s11701-023-01687-8. Epub 2023 Aug 1. J Robot Surg. 2023. PMID: 37528286 Free PMC article.
Retzius-sparing robot-assisted radical prostatectomy in a medium size oncological center holds adequate oncological and functional outcomes.
Fonseca J, Moraes-Fontes MF, Rebola J, Lúcio R, Almeida M, Muresan C, Palmas A, Gaivão A, Matos C, Santos T, Dias D, Sousa I, Oliveira F, Ribeiro R, Lopez-Beltran A, Fraga A. Fonseca J, et al. J Robot Surg. 2023 Jun;17(3):1133-1142. doi: 10.1007/s11701-022-01517-3. Epub 2023 Jan 12. J Robot Surg. 2023. PMID: 36633734 Free PMC article.
1,719 results